By Dr Eugene Kotlyar

Journal articles

Gorrie N; Montgomery E; Kessler C; Fatkin D; Hayward C; Macdonald P; Jabbour A; Kotlyar E; Muthiah K; McCaughan G; S. A; Bart NK, 2024, 'Cardiac transplantation for transthyretin amyloidosis (ATTR): A single centre experience', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f5b7

Kearney K; Brown K; Celermajer DS; Collins N; Cordina R; Corrigan C; Dwyer N; Feenstra J; Keating D; Keogh A; Kotlyar E; Lavender M; McWilliams T; Williams T; Whitford H; Weintraub R; Wrobel J; Ellender C; Anderson J; Lau EM, 2024, 'Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy', Chest, 165, pp. 967 - 977, http://dx.doi.org/10.1016/j.chest.2023.10.037

Lau E; Kotlyar E; Makanji Y; Yu DY; Tan JY; Casorso J; Kouhkamari MH; Lim S; Wu DBC; Bloomfield P, 2024, 'Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study', Journal of Medical Economics, 27, pp. 596 - 604, http://dx.doi.org/10.1080/13696998.2024.2328483

Pouliopoulos J; Anthony C; Imran M; Graham RM; McCrohon J; Holloway C; Kotlyar E; Muthiah K; Keogh AM; Hayward CS; Macdonald PS; Jabbour A, 2024, 'Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System', Heart Lung and Circulation, http://dx.doi.org/10.1016/j.hlc.2024.03.004

Raven LM; Muir CA; Deveza RC; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Hayward CS; Macdonald PS; Jabbour A; Greenfield JR, 2024, 'Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation', JHLT Open, pp. 100088 - 100088, http://dx.doi.org/10.1016/j.jhlto.2024.100088

Jeyakumar S; Jeyakumar R; Robson D; Honeysett L; Raven L; Campos Deveza e Silva R; Jabbour A; Kotlyar E; Keogh A; Greenfield J; MacDonald P; Hayward C; Muthiah K, 2024, 'Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in End-Stage Heart Failure Patients Considered for Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S106 - S106, http://dx.doi.org/10.1016/j.healun.2024.02.213

Hungerford S; Kearney K; Song N; Everett K; Gulati G; Lau E; Jabbour A; Kotlyar E; Bart N; Muller DWM; Kapur N; Adji A, 2024, 'OPTIMAL MODELLING FOR RIGHT VENTRICULAR AFTERLOAD ASSESSMENT IN PULMONARY HYPERTENSION', Journal of the American College of Cardiology, 83, pp. 2087 - 2087, http://dx.doi.org/10.1016/s0735-1097(24)04077-4

Raven LM; Muir CA; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Hayward CS; Macdonald PS; Jabbour A; Greenfield JR, 2024, 'Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S148 - S149, http://dx.doi.org/10.1016/j.healun.2024.02.302

Hayes AG; Raven LM; Viardot A; Kotlyar E; Greenfield JR, 2023, 'SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes', Diabetes Care, 47, pp. e4 - e5, http://dx.doi.org/10.2337/dc23-1903

Raven LM; Muir CA; Kessler Iglesias C; Kotlyar E; Muthiah K; Bart NK; Macdonald PS; Hayward CS; Jabbour A; Greenfield JR, 2023, 'THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design', Journal of the Endocrine Society, 7, http://dx.doi.org/10.1210/jendso/bvad114.733

Penglase R; Girgis L; Englert H; Brennan X; Jabbour A; Kotlyar E; Ma D; Moore J, 2023, 'Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis', Journal of Scleroderma and Related Disorders, 8, pp. 87 - 100, http://dx.doi.org/10.1177/23971983221145639

Bart N; Hungerford S; Emmanuel S; Kotlyar E; Keogh A; MacDonald P; Muller D; Hayward C, 2023, 'Pre-operative pulmonary artery pulsatility index does not predict mortality post-cardiac transplantation', ESC Heart Failure, 10, pp. 1980 - 1986, http://dx.doi.org/10.1002/ehf2.14226

Hungerford SL; Kearney K; Song N; Bart N; Kotlyar E; Lau E; Jabbour A; Hayward CS; Muller DWM; Adji A, 2023, 'Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension', ESC Heart Failure, 10, pp. 1811 - 1821, http://dx.doi.org/10.1002/ehf2.14180

Bart NK; Hungerford SL; Namasivayam M; Granger E; Conellan M; Kotlyar E; Muthiah K; Jabbour A; Hayward C; Jansz PC; Keogh AM; MacDonald PS, 2023, 'Tricuspid Regurgitation After Heart Transplantation: The Cause or the Result of Graft Dysfunction?', Transplantation, 107, pp. 1390 - 1397, http://dx.doi.org/10.1097/TP.0000000000004511

Wiltshire S; Conte S; Tanio D; KotIrar E; Kearney K; Lau E; MacDonald P; Boshell D; Conlina R, 2023, 'A Case of Diffuse Distal Congenital Pulmonary Artery Hypoplasia Successfully Treated with Pulmonary Artery Stenting', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S420 - S420, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wassif M; Lo P; Satouris P; Swan L; Tardo D; Kovacic JC; Muller D; Muthiah K; Kotlyar E; Bart NK, 2023, 'Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis', Heart Lung and Circulation, 32, pp. 467 - 479, http://dx.doi.org/10.1016/j.hlc.2023.01.002

Hungerford S; Kearney K; Song N; Kotlyar E; Bart NK; Lau E; Jabbour A; Hayward CS; Muller DWM; Adji A, 2023, 'Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification', Physiological Reports, 11, http://dx.doi.org/10.14814/phy2.15662

Gorrie N; Sivasubramaniam D; Muthiah K; Kotlyar E; Jabbour A; Hayward C; MacDonald P; Bart N, 2023, 'Clinical and Histopathological Cardiomyopathy Diagnosis Discrepancies in Heart Transplant', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S121 - S122, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480600246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kearney K; Cordina R; Choudhary P; Tanous D; Celermajer D; Keogh A; Bart N; Jabbour A; Kotlyar E; Jansz P; Hayward C; Muthiah K; MacDonald P, 2023, 'Post-Transplantation Outcomes of Adult Congenital Heart Disease', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S444 - S445, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gorrie N; MacDonald P; Sivasubramaniam V; Jabbour A; Muthiah K; Fatkin D; Kotlyar E; Hayward C; Bart N, 2023, 'Prevalence of Incidental Amyloid on Cardiac', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S427 - S428, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601218&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Buckley D; Aspinal D; Carroll R; Hayward C; Kotlyar E; Jabbour A; Bart N; Keogh A; MacDonald P; Muthiah K; Tong W, 2023, 'Routine Donor Specific Antibody Monitoring in Heart Transplant Recipients - Is There a Role?', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S429 - S429, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480601222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kearney K; Jain P; Adji A; Muthiah K; Robson D; Chemla D; Kotlyar E; Jabbour A; Hayward C; Lau EM, 2023, 'The Effect of Acute Alterations in Left Atrial Pressure on Rc Time in the Pulmonary Circulation', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 42, pp. S326 - S326, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000992480600727&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Raven LM; Muir CA; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Macdonald P; Hayward CS; Jabbour A; Greenfield JR, 2023, 'Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): Protocol for a randomised controlled trial', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-069641

Chandrasekara S; Lau EM; Anderson J; Collins N; Cordina R; Corrigan C; Dwyer N; Feenstra J; Horrigan M; Keogh A; Kotlyar E; Lavender M; McWilliams T; Rhodes B; Steele P; Strange G; Thakkar V; Weintraub R; Whitford H; Whyte K; Williams T; Wrobel J; Keating DT, 2023, 'Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing', Heart Lung and Circulation, 32, pp. 156 - 165, http://dx.doi.org/10.1016/j.hlc.2022.09.005

Joshi Y; Scheuer S; Chew H; Ru Qiu M; Soto C; Villanueva J; Gao L; Doyle A; Takahara S; Jenkinson C; Vaidhya N; Matsumoto Y; Hwang B; Zhao C; Iyer A; Connellan M; Watson A; Granger E; Muthiah K; Jabbour A; Kotlyar E; Keogh A; Bart NK; Hayward C; Dhital K; Jansz P; Macdonald PS, 2023, 'Heart Transplantation from DCD Donors in Australia: Lessons Learned from the First 74 Cases', Transplantation, 107, pp. 361 - 371, http://dx.doi.org/10.1097/TP.0000000000004294

Bart NK; Emmanuel S; Friits-Lamora R; Larkins E; Kotlyar E; Muthiah K; Jabbour A; Hayward C; Jansz PC; Keogh AM; Thomas E; Macdonald PS, 2023, 'Rapid triage and transition to telehealth for heart transplant patients in the COVID-19 pandemic setting', Journal of Telemedicine and Telecare, http://dx.doi.org/10.1177/1357633X231151714

Gorrie N; Kaur G; Bart N; Girgis L; Kotlyar E, 2023, '(847) Turning Back The Clock; A Unique Case of Reversible Pulmonary Hypertension', The Journal of Heart and Lung Transplantation, 42, pp. S370 - S370, http://dx.doi.org/10.1016/j.healun.2023.02.860

Wassif M; Lo P; Satouris P; Swan L; Tardo D; Kovacic J; Muller D; Muthiah K; Kotlyar E; Bart N, 2023, 'Acute Myocarditis and Pericarditis After M-RNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis', Heart, Lung and Circulation, 32, pp. S265 - S265, http://dx.doi.org/10.1016/j.hlc.2023.06.334

Tardo D; Carlos L; Burrows F; Carroll R; Tong W; Patel P; Taverniti A; Wiltshire S; Conte S; Parvar S; Emmanuel S; Grealy R; Hayward C; Bart N; Kotlyar E; Jabbour A; Keogh A; Patel J; Jansz P; Macdonald P; Muthiah K, 2023, 'Combined Plasmapheresis and Complement Inhibition in a Highly Allosensitised Cardiac Transplant Recipient', Heart, Lung and Circulation, 32, pp. S147 - S148, http://dx.doi.org/10.1016/j.hlc.2023.06.057

Gorrie N; Sivasubramaniam V; Jabbour A; Kotlyar E; Muthiah K; Hayward C; Macdonald P; Bart N, 2023, 'Discrepancies in the Clinical and Histopathological Diagnosis of Cardiomyopathy in a Heart Transplant Cohort', Heart, Lung and Circulation, 32, pp. S152 - S152, http://dx.doi.org/10.1016/j.hlc.2023.06.068

Song N; Kearney K; Phan J; Kessler C; Gorrie N; Brennan X; Deveza R; Situ Y; Kempton H; Cherrett C; Wiltshire S; Conte S; Tardo D; Lo P; Wong N; Cao J; Burrows F; Carlos L; Bart N; Jabbour A; Kotlyar E; Keogh A; Hayward C; Macdonald P; Muthiah K, 2023, 'Intensive Tacrolimus Level Monitoring After Itraconazole Prophylaxis Cessation Reduces Acute Cellular Rejection Following Heart Transplant', Heart, Lung and Circulation, 32, pp. S164 - S164, http://dx.doi.org/10.1016/j.hlc.2023.06.095

Buckley D; Aspinall D; Carroll R; Hayward C; Kotlyar E; Jabbour A; Bart N; Keogh A; Macdonald P; Muthiah K; Tong W, 2023, 'Routine Donor-Specific Antibody Monitoring in Heart Transplant Recipients: Is There a Role?', Heart, Lung and Circulation, 32, pp. S176 - S176, http://dx.doi.org/10.1016/j.hlc.2023.06.122

Bart NK; Kotlyar E; Keogh AM, 2022, 'Pulmonary haemodynamics and pulmonary congestion: where are we now?', European Heart Journal, 43, pp. 4515, http://dx.doi.org/10.1093/eurheartj/ehac499

Brennan X; Withers B; Jabbour A; Milliken S; Kotlyar E; Fay K; Ma D; Muthiah K; Hamad N; Dodds A; Bart N; Keogh A; Hayward C; Macdonald P; Moore J, 2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926

Bart NK; Liu K; Kotlyar E; Keogh AM, 2022, 'Portopulmonary Hypertension: The Interplay Between the Liver and Pulmonary Arteries', Heart Lung and Circulation, 31, pp. 1185 - 1187, http://dx.doi.org/10.1016/j.hlc.2022.07.010

Anthony C; Imran M; Pouliopoulos J; Emmanuel S; Iliff J; Liu Z; Moffat K; Ru Qiu M; McLean CA; Stehning C; Puntmann V; Vassiliou V; Ismail TF; Gulati A; Prasad S; Graham RM; McCrohon J; Holloway C; Kotlyar E; Muthiah K; Keogh AM; Hayward CS; MacDonald PS; Jabbour A, 2022, 'Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation', Circulation, 145, pp. 1811 - 1824, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057006

Muthiah K; Wilhelm K; Robson D; Raju H; Aili SR; Jha SR; Pierce R; Fritis-Lamora R; Montgomery E; Gorrie N; Deveza R; Brennan X; Schnegg B; Jabbour A; Kotlyar E; Keogh AM; Bart N; Conellan M; Iyer A; Watson A; Granger E; Jansz PC; Hayward C; Macdonald PS, 2022, 'Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support', Journal of Heart and Lung Transplantation, 41, pp. 829 - 839, http://dx.doi.org/10.1016/j.healun.2022.02.008

Chen Y; Luo J; Chen J; Kotlyar E; Li Z; Chen W; Li J, 2022, 'Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study (Front Pharmacol., (2022), 12, 811700, 10.3389/fphar.2021.811700)', Frontiers in Pharmacology, 13, http://dx.doi.org/10.3389/fphar.2022.891907

Chia KSW; Shiner C; Brown K; Holloway C; Moreyra C; Bart N; Wong PKK; Faux SG; Kotlyar E, 2022, 'The exercise in pulmonary arterial hypertension (ExPAH) study: A randomized controlled pilot of exercise training and multidisciplinary rehabilitation in pulmonary arterial hypertension', Pulmonary Circulation, 12, http://dx.doi.org/10.1002/pul2.12069

Chen Y; Luo J; Chen J; Kotlyar E; Li Z; Chen W; Li J, 2022, 'The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study', Frontiers in Pharmacology, 12, http://dx.doi.org/10.3389/fphar.2021.811700

Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072

Aili SR; De Silva R; Wilhelm K; Jha SR; Fritis-Lamora R; Montgomery E; Pierce R; Lam F; Brennan X; Gorrie N; Schnegg B; Jabbour A; Kotlyar E; Muthiah K; Keogh AM; Jansz PC; Hayward C; Macdonald PS, 2022, 'Validation of Cognitive Impairment in Combination with Physical Frailty as a Predictor of Mortality in Patients with Advanced Heart Failure Referred for Heart Transplantation', Transplantation, 106, pp. 200 - 209, http://dx.doi.org/10.1097/TP.0000000000003669

Gorrie N; Evans D; Kotlyar E; Watson A; Bart N, 2022, 'HIGH OUTPUT HEART FAILURE: A COMPLEX CASE OF AV MALFORMATION AND MULTI-ORGAN FAILURE', Journal of the American College of Cardiology, 79, pp. 2669 - 2669, http://dx.doi.org/10.1016/s0735-1097(22)03660-9

Kearney K; Lavender M; Cordina R; Collins N; Corrigan C; Dwyer N; Feenstra J; Keating D; McWilliams T; Williams T; Whitford H; Whyte K; Weintraub R; Wrobel J; Keogh A; Kotlyar E; Lau E, 2022, 'Impact of Initial Therapeutic Strategy on Long-Term Outcomes in Pulmonary Arterial Hypertension: An Analysis of the PHSANZ Registry', Heart, Lung and Circulation, 31, pp. S86 - S86, http://dx.doi.org/10.1016/j.hlc.2022.06.095

Kearney K; Gold J; Corrigan C; Dhital K; Boshell D; Haydock D; McGiffin D; Wilson M; Collins N; Cordina R; Dwyer N; Feenstra J; Lavender M; Wrobel J; Whitford H; Williams T; Keating D; Whyte K; McWilliams T; Keogh A; Strange G; Kotlyar E; Anderson J; Lau EMT, 2021, 'Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry', Respirology, 26, pp. 1171 - 1180, http://dx.doi.org/10.1111/resp.14162

Kearney K; Anderson J; Cordina R; Lavender M; Celermajer D; Collins N; Dwyer N; Keating D; Williams T; Whitford H; Whyte K; Weintraub R; Keogh A; Kotlyar E; Lau EMT, 2021, 'Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension', EUROPEAN HEART JOURNAL, 42, pp. 1958 - 1958, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000720456902159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kearney K; Lau EM; Darley D; Romfh A; Bart N; Kotlyar E; Hayes D; Khush K; Keogh A, 2021, 'Waitlist and post-transplant outcomes for eisenmenger syndrome: A comparison of transplant strategies', Journal of Heart and Lung Transplantation, 40, pp. 841 - 849, http://dx.doi.org/10.1016/j.healun.2021.04.005

Anthony C; Imran M; Pouliopoulos J; Emmanuel S; Iliff JW; Moffat KJ; Ross J; Graham RM; Kotlyar E; Muthiah K; Keogh AM; Hayward CS; Macdonald P; Jabbour A, 2021, 'Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study)', JACC: Heart Failure, 9, pp. 301 - 313, http://dx.doi.org/10.1016/j.jchf.2021.01.007

Kearney K; Kotlyar E; Lau EMT, 2021, 'Pulmonary Vascular Disease as a Systemic and Multisystem Disease', Clinics in Chest Medicine, 42, pp. 167 - 177, http://dx.doi.org/10.1016/j.ccm.2020.11.001

Ghofrani HA; Gomez Sanchez MA; Humbert M; Pittrow D; Simonneau G; Gall H; Grünig E; Klose H; Halank M; Langleben D; Snijder RJ; Escribano Subias P; Mielniczuk LM; Lange TJ; Vachiéry JL; Wirtz H; Helmersen DS; Tsangaris I; Barberá JA; Pepke-Zaba J; Boonstra A; Rosenkranz S; Ulrich S; Steringer-Mascherbauer R; Delcroix M; Jansa P; Šimková I; Giannakoulas G; Klotsche J; Williams E; Meier C; Hoeper MM; Caneva J; Tuhay G; Diez M; Talavera ML; Acosta A; Vulcano N; Bosio M; Maldonado L; Deleo S; Melatini L; Keogh A; Kotlyar E; Feenstra J; Dwyer N; Adams H; Stevens W; Steele P; Proudman S; Minson R; Reeves G; Lavender M; Ng B; Mackenzie M; Barry L; Gruenberger M; Huber C; Lang I; Tilea I; Sadushi-Kolici R; Löffler-Ragg J; Feistmantl LT; Evrard P; Louis R; Guiot J; Naldi M; De Pauw M; Mehta S; Camacho RC; Tovar PP; Londoño A; Campo F; Garcia P; Lema C; Orozco-Levi M; Martinez W; Gomez JE; Nielsen-Kudsk JE; Mellemkjaer S; Anton L; Altraja A; Vihinen T; Vasankari T; Sitbon O; Cottin V; Têtu L; Noël-Savina E; Shearman N; Tayler S; Olzik I; Kulka C; Grimminger J; Simon M; Nolde A; Oqueka T; Harbaum L; Egenlauf B; Ewert R; Schulz C, 2021, 'Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry', Respiratory Medicine, 178, http://dx.doi.org/10.1016/j.rmed.2020.106220

Back to profile page